F
The Motley Fool News source @fool.com · 2w

#Exelixis #Oncology #Cabozantinib

Link Preview
www.fool.com
Exelixis (EXEL) Q4 2025 Earnings Call Transcript
Tuesday, February 10, 2026 at 5:00 p. m. ET Call participants * President and Chief Executive Officer -- Michael Morrissey * Chief Financial Officer -- Christopher Senner * Executive Vice President, Research & Development -- Dana Aftab * Executive Vice President, Commercial -- Patrick Joseph Haley Need a quote from a Motley Fool analyst.